20110613
 Corporate News: Vaccine Funding Gap Plugged --- Global Charity Raises $4.3 Billion From Donors to Safeguard Immunization Plans   By Whalen, Jeanne, The Wall Street Journal,  Jun 14, 2011  U.K. drug maker GlaxoSmithKline PLC is one of the biggest recipients of GAVI funds, supplying the agency with vaccines for pneumococcal disease; rotavirus, which causes severe diarrhea; and other diseases.   
